Trial Profile

Phase I Clinical Trial of HSV G207 Alone or With a Single Radiation Dose in Children With Recurrent Supratentorial Brain Tumors

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs G 207 (Primary)
Indications Anaplastic astrocytoma; Brain cancer; Ependymoma; Germ cell and embryonal neoplasms; Germ cell cancer; Giant cell tumours; Glioblastoma; Glioma; Neuroectodermal tumours; Rhabdoid tumour; Teratoma
Focus Adverse reactions

Most Recent Events

18 Jan 2024 Status changed from active, no longer recruiting to completed.
30 Jan 2023 Planned End Date changed from 1 Dec 2022 to 1 Jan 2024.
01 Jun 2022 Planned End Date changed from 1 Jun 2022 to 1 Dec 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com